AIN Holdings Inc
TSE:9627
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4 303
6 281
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
AIN Holdings Inc
Total Liabilities & Equity
AIN Holdings Inc
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
AIN Holdings Inc
TSE:9627
|
Total Liabilities & Equity
ÂĄ248.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
||
Sundrug Co Ltd
TSE:9989
|
Total Liabilities & Equity
ÂĄ416.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
||
Tsuruha Holdings Inc
TSE:3391
|
Total Liabilities & Equity
ÂĄ556.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
||
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Total Liabilities & Equity
ÂĄ446.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Total Liabilities & Equity
ÂĄ716.2B
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
||
Cosmos Pharmaceutical Corp
TSE:3349
|
Total Liabilities & Equity
ÂĄ485B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
AIN Holdings Inc
Glance View
Ain Holdings, Inc. engages in the operation of dispensing pharmacies and drug stores. The company is headquartered in Sapporo, Hokkaido and currently employs 9,019 full-time employees. The firm has three business segments. The Pharmacy segment operates and franchises pharmacies, and provides consulting services related to opening pharmacies. Through its subsidiaries, this segment is also involved in the provision of consultation services for medical-related affairs and manpower dispatching of doctors and pharmacists, as well as the sale of generic drugs. The Retail segment operates cosmetics business and drugstores. The Others segment is engaged in the leasing of buildings and the sales of cosmetics.
See Also
What is AIN Holdings Inc's Total Liabilities & Equity?
Total Liabilities & Equity
248.1B
JPY
Based on the financial report for Jul 31, 2024, AIN Holdings Inc's Total Liabilities & Equity amounts to 248.1B JPY.
What is AIN Holdings Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
9%
Over the last year, the Total Liabilities & Equity growth was 5%. The average annual Total Liabilities & Equity growth rates for AIN Holdings Inc have been 7% over the past three years , 6% over the past five years , and 9% over the past ten years .